NDC00013-1096-94: DOXORUBICIN HYDROCHLORIDE FOR IN.
DOXORUBICIN HYDROCHLORIDE FOR IN. Key specifications include physical_form: FREEZE-DRIED POWDER, administration: INTRAVENOUS, special_features: 100 MILLIGRAMS OF LACTOSE, features_provided: STERILE, primary_container_type: VIAL, medical_designation_and_grade: UNITED STATES PHARMACOPEIA. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-273-4239, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| physical_form | FREEZE-DRIED POWDER |
| administration | INTRAVENOUS |
| special_features | 100 MILLIGRAMS OF LACTOSE |
| features_provided | STERILE |
| primary_container_type | VIAL |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| total_primary_container_quantity | 5 |
| primary_container_content_quantity | 20.000 MILLIGRAMS |
| active_medicament_medicinal_strength | 20.000 MILLIGRAMS DOXORUBICIN HYDROCHLORIDE ACTIVE INGREDIENT |
| NSN | 6505-01-273-4239 |
| ADMINISTRATION | INTRAVENOUS |
| PRIMARY CONTAINER CONTENT QUANTITY | 20.000 MILLIGRAMS |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| FEATURES PROVIDED | STERILE |
| PRIMARY CONTAINER TYPE | VIAL |
| PHYSICAL FORM | FREEZE-DRIED POWDER |
| SPECIAL FEATURES | 100 MILLIGRAMS OF LACTOSE |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 20.000 MILLIGRAMS DOXORUBICIN HYDROCHLORIDE ACTIVE INGREDIENT |
| TOTAL PRIMARY CONTAINER QUANTITY | 5 |